- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic biomarkers in endometrial and ovarian carcinoma
Authors
Keywords
Endometrial carcinoma, Ovarian carcinoma, Biomarkers, Prognosis
Journal
VIRCHOWS ARCHIV
Volume 464, Issue 3, Pages 315-331
Publisher
Springer Nature
Online
2014-02-06
DOI
10.1007/s00428-013-1509-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of Class I Histone Deacetylases Indicates Poor Prognosis in Endometrioid Subtypes of Ovarian and Endometrial Carcinomas
- (2015) Wilko Weichert et al. NEOPLASIA
- LAPTM4Bgene polymorphism and endometrial carcinoma risk and prognosis
- (2013) Fanling Meng et al. BIOMARKERS
- Low expression of the X-linked ribosomal protein S4 in human serous epithelial ovarian cancer is associated with a poor prognosis
- (2013) Serges P Tsofack et al. BMC CANCER
- Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance
- (2013) C Palmieri et al. BRITISH JOURNAL OF CANCER
- Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome
- (2013) K. L. White et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer
- (2013) T. M. Zaid et al. CLINICAL CANCER RESEARCH
- High Phospho-Stathmin(Serine38) Expression Identifies Aggressive Endometrial Cancer and Suggests an Association with PI3K Inhibition
- (2013) E. Wik et al. CLINICAL CANCER RESEARCH
- New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential
- (2013) S. Banerjee et al. CLINICAL CANCER RESEARCH
- Trefoil factor family 3 (TFF3) expression and its interaction with estrogen receptor (ER) in endometrial adenocarcinoma
- (2013) Paulette Mhawech-Fauceglia et al. GYNECOLOGIC ONCOLOGY
- HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival
- (2013) Helene Tuft Stavnes et al. GYNECOLOGIC ONCOLOGY
- Visfatin, a potential biomarker and prognostic factor for endometrial cancer
- (2013) Wenyan Tian et al. GYNECOLOGIC ONCOLOGY
- Prognostic role of cyclooxygenase-2 in epithelial ovarian cancer: A meta-analysis of observational studies
- (2013) Jung-Yun Lee et al. GYNECOLOGIC ONCOLOGY
- Poly(adenosine diphosphate-ribose) polymerase expression in BRCA-proficient ovarian high-grade serous carcinoma; association with patient survival
- (2013) Alex Gan et al. HUMAN PATHOLOGY
- Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma
- (2013) Catarina Alisa Liebscher et al. HUMAN PATHOLOGY
- Overexpression of Wnt7a Is Associated With Tumor Progression and Unfavorable Prognosis in Endometrial Cancer
- (2013) Yunduo Liu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
- (2013) Weiva Sieh et al. LANCET ONCOLOGY
- Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells
- (2013) Laura Bergadà et al. Molecular Oncology
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Stem Cell-Like Gene Expression in Ovarian Cancer Predicts Type II Subtype and Prognosis
- (2013) Matthew Schwede et al. PLoS One
- Integrated Genomic Analysis of the 8q24 Amplification in Endometrial Cancers Identifies ATAD2 as Essential to MYC-Dependent Cancers
- (2013) Maria B. Raeder et al. PLoS One
- Value of PAX 8 Immunostaining in Tumor Diagnosis
- (2012) Nelson G. Ordóñez ADVANCES IN ANATOMIC PATHOLOGY
- Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation
- (2012) S. Bondong et al. ANNALS OF ONCOLOGY
- Lipocalin 2 expression is associated with aggressive features of endometrial cancer
- (2012) Monica Mannelqvist et al. BMC CANCER
- Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome
- (2012) C Krakstad et al. BRITISH JOURNAL OF CANCER
- Associations between hepatocyte growth factor, c-Met and basic fibroblast growth factor and survival in endometrial cancer patients
- (2012) A S Felix et al. BRITISH JOURNAL OF CANCER
- KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer
- (2012) E Birkeland et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Biologic rationale and clinical activity of mTOR inhibitors in gynecological cancer
- (2012) Ivan Diaz-Padilla et al. CANCER TREATMENT REVIEWS
- Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: A gynecologic oncology group study
- (2012) Jennifer M. Rubatt et al. GYNECOLOGIC ONCOLOGY
- Pair Box 8 (PAX8) protein expression in high grade, late stage (stages III and IV) ovarian serous carcinoma
- (2012) Paulette Mhawech-Fauceglia et al. GYNECOLOGIC ONCOLOGY
- Somatic hypermutation and outcomes of platinum based chemotherapy in patients with high grade serous ovarian cancer
- (2012) Insuk Sohn et al. GYNECOLOGIC ONCOLOGY
- Prognostic role of indoleamine 2,3-dioxygenase in endometrial carcinoma
- (2012) Renske A. de Jong et al. GYNECOLOGIC ONCOLOGY
- Validation of ovarian cancer gene expression signatures for survival and subtype in formalin fixed paraffin embedded tissues
- (2012) Gregory P. Sfakianos et al. GYNECOLOGIC ONCOLOGY
- Migfilin, α-parvin and β-parvin are differentially expressed in ovarian serous carcinoma effusions, primary tumors and solid metastases
- (2012) Ben Davidson et al. GYNECOLOGIC ONCOLOGY
- The prognostic value of vascular endothelial growth factor in ovarian cancer: A systematic review and meta-analysis
- (2012) Lei Yu et al. GYNECOLOGIC ONCOLOGY
- High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma
- (2012) Diego A. Garcia-Dios et al. GYNECOLOGIC ONCOLOGY
- Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: role for proteins involved in resistance to apoptosis and hypoxia
- (2012) Maria Santacana et al. HISTOPATHOLOGY
- Elevated expression of astrocyte elevated gene-1 (AEG-1) is correlated with cisplatin-based chemoresistance and shortened outcome in patients with stages III-IV serous ovarian carcinoma
- (2012) Cong Li et al. HISTOPATHOLOGY
- Key features of extrauterine pelvic serous tumours (fallopian tube, ovary, and peritoneum)
- (2012) Deborah DeLair et al. HISTOPATHOLOGY
- PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma
- (2012) Azusa Abe et al. HUMAN PATHOLOGY
- Loss of HLA class I and mismatch repair protein expression in sporadic endometrioid endometrial carcinomas
- (2012) Renske A. de Jong et al. INTERNATIONAL JOURNAL OF CANCER
- Clear Cell Carcinomas of the Ovary
- (2012) Kyueng-Whan Min et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancer
- (2012) Jaeline E Spowart et al. JOURNAL OF PATHOLOGY
- A DNA Repair Pathway–Focused Score for Prediction of Outcomes in Ovarian Cancer Treated With Platinum-Based Chemotherapy
- (2012) Josephine Kang et al. JNCI-Journal of the National Cancer Institute
- Contemporary management of endometrial cancer
- (2012) Jason D Wright et al. LANCET
- Markers for individualised therapy in endometrial carcinoma
- (2012) Helga B Salvesen et al. LANCET ONCOLOGY
- Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -A study of the OVCAD consortium
- (2012) Stefanie Aust et al. Molecular Cancer
- Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells
- (2012) Anabel Sorolla et al. Molecular Oncology
- Endometrial carcinoma: molecular alterations involved in tumor development and progression
- (2012) A Yeramian et al. ONCOGENE
- Differing clinical impact ofBRCA1andBRCA2mutations in serous ovarian cancer
- (2012) Guoyan Liu et al. PHARMACOGENOMICS
- FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features
- (2012) Sara A. Byron et al. PLoS One
- Prognostic Significance of miR-205 in Endometrial Cancer
- (2012) Mihriban Karaayvaz et al. PLoS One
- Genotype-Dependent Efficacy of a Dual PI3K/mTOR Inhibitor, NVP-BEZ235, and an mTOR Inhibitor, RAD001, in Endometrial Carcinomas
- (2012) Keiko Shoji et al. PLoS One
- Anterior gradient protein 2 (AGR2) is an independent prognostic factor in ovarian high-grade serous carcinoma
- (2012) S. Darb-Esfahani et al. VIRCHOWS ARCHIV
- Rab25 is overexpressed in Müllerian serous carcinoma compared to malignant mesothelioma
- (2012) Kjersti Brusegard et al. VIRCHOWS ARCHIV
- Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
- (2012) Jaime Prat VIRCHOWS ARCHIV
- Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspective
- (2011) MARI B. ELSTRAND et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- WT1 Expression in the Female Genital Tract
- (2011) Carmen Bárcena et al. ADVANCES IN ANATOMIC PATHOLOGY
- Gene Expression Patterns Related to Vascular Invasion and Aggressive Features in Endometrial Cancer
- (2011) Monica Mannelqvist et al. AMERICAN JOURNAL OF PATHOLOGY
- Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an NCIC CTG OV.16 correlative study
- (2011) J. I. Weberpals et al. ANNALS OF ONCOLOGY
- Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium
- (2011) M. Pradhan et al. ANNALS OF ONCOLOGY
- A seven-gene prognostic model for platinum-treated ovarian carcinomas
- (2011) R Sabatier et al. BRITISH JOURNAL OF CANCER
- Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma
- (2011) Mohammed Tanjimur Rahman et al. CANCER
- Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas
- (2011) David S.P. Tan et al. CLINICAL CANCER RESEARCH
- BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer
- (2011) Judith E. Carser et al. GYNECOLOGIC ONCOLOGY
- Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma
- (2011) Paulette Mhawech-Fauceglia et al. GYNECOLOGIC ONCOLOGY
- Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
- (2011) Wei-Ting Hwang et al. GYNECOLOGIC ONCOLOGY
- Class III β-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance
- (2011) Thea Eline Hetland et al. HUMAN PATHOLOGY
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions
- (2011) Mari Bunkholt Elstrand et al. HUMAN PATHOLOGY
- Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer
- (2011) Frederik Marmé et al. INTERNATIONAL JOURNAL OF CANCER
- Pathology of primary and metastatic mucinous ovarian neoplasms
- (2011) Sarah Lam Shang Leen et al. JOURNAL OF CLINICAL PATHOLOGY
- Immunohistochemistry in the distinction between primary and metastatic ovarian mucinous neoplasms: Table 1
- (2011) W Glenn McCluggage JOURNAL OF CLINICAL PATHOLOGY
- TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions
- (2011) Elisabetta Kuhn et al. JOURNAL OF PATHOLOGY
- AURKA and BRCA2 expression highly correlate with prognosis of endometrioid ovarian carcinoma
- (2011) Fan Yang et al. MODERN PATHOLOGY
- Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma
- (2011) Anita Steinbakk et al. MODERN PATHOLOGY
- Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient
- (2011) Sohei Yamamoto et al. MODERN PATHOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Integrated Analysis of Multiple Microarray Datasets Identifies a Reproducible Survival Predictor in Ovarian Cancer
- (2011) Panagiotis A. Konstantinopoulos et al. PLoS One
- Microarray-Based Oncogenic Pathway Profiling in Advanced Serous Papillary Ovarian Carcinoma
- (2011) Xuan Bich Trinh et al. PLoS One
- Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status
- (2011) Annika J. Bock et al. TUMOR BIOLOGY
- PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma
- (2011) Sohei Yamamoto et al. VIRCHOWS ARCHIV
- The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms
- (2010) D. Llobet et al. EUROPEAN JOURNAL OF CANCER
- Identification of a Gene Expression Signature for Survival Prediction in Type I Endometrial Carcinoma
- (2010) KRISTINA LEVAN et al. GENE EXPRESSION
- MicroRNA signatures differentiate uterine cancer tumor subtypes
- (2010) Elena S. Ratner et al. GYNECOLOGIC ONCOLOGY
- “Primary peritoneal” high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: Assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer
- (2010) Jeffrey D. Seidman et al. GYNECOLOGIC ONCOLOGY
- Aromatase, Cyclooxygenase 2, HER-2/neu, and P53 as Prognostic Factors in Endometrioid Endometrial Cancer
- (2010) Vincent H.W.M. Jongen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Gene Expression Profiling of Endometrial Adenocarcinomas Reveals Increased Apolipoprotein E Expression in Poorly Differentiated Tumors
- (2010) Jutta Huvila et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Molecular classification of human endometrial cancer based on gene expression profiles from specialized microarrays
- (2010) YuanYang Yao et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type
- (2010) B. A. Clarke et al. JOURNAL OF CLINICAL PATHOLOGY
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
- (2010) Ahmed Ashour Ahmed et al. JOURNAL OF PATHOLOGY
- PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors
- (2010) K. J. Dedes et al. Science Translational Medicine
- Resistance to chemotherapy and hormone therapy in endometrial cancer
- (2009) Parvesh Chaudhry et al. ENDOCRINE-RELATED CANCER
- Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer
- (2009) Ninke Leffers et al. GYNECOLOGIC ONCOLOGY
- Cleaved caspase-3 and nuclear factor-κB p65 are prognostic factors in metastatic serous ovarian carcinoma
- (2009) Lilach Kleinberg et al. HUMAN PATHOLOGY
- Ovarian cancer
- (2009) Bryan T Hennessy et al. LANCET
- IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype
- (2009) Martin Köbel et al. MODERN PATHOLOGY
- Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
- (2009) Katy Milne et al. PLoS One
- Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation
- (2009) H. B. Salvesen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer
- (2008) P de Graeff et al. BRITISH JOURNAL OF CANCER
- The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro
- (2008) P M O'Brien et al. BRITISH JOURNAL OF CANCER
- Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
- (2008) Ninke Leffers et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- Increased HLA-DMB Expression in the Tumor Epithelium Is Associated with Increased CTL Infiltration and Improved Prognosis in Advanced-Stage Serous Ovarian Cancer
- (2008) M. J. Callahan et al. CLINICAL CANCER RESEARCH
- Adjuvant Chemotherapy in Endometrial Carcinoma: Overview of Randomised Trials
- (2008) T. Hogberg CLINICAL ONCOLOGY
- Amplification of 11q13 in ovarian carcinoma
- (2008) Lindsay A. Brown et al. GENES CHROMOSOMES & CANCER
- The prognostic significance of elongation factor eEF1A2 in ovarian cancer
- (2008) Dixie E. Pinke et al. GYNECOLOGIC ONCOLOGY
- Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer
- (2008) Vincent Jongen et al. GYNECOLOGIC ONCOLOGY
- Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma
- (2008) C. Blake Gilks et al. HUMAN PATHOLOGY
- Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints
- (2008) D Llobet et al. JOURNAL OF CLINICAL PATHOLOGY
- Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type and BRCA1 loss
- (2008) Blaise Clarke et al. MODERN PATHOLOGY
- Drug-sensitive FGFR2 mutations in endometrial carcinoma
- (2008) A. Dutt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted therapies in gynecologic cancers and melanoma
- (2008) Eugenia Ortega et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
- (2008) Martin Köbel et al. PLOS MEDICINE
- Reproducibility of grading systems for endometrial endometrioid carcinoma and their relation with pathologic prognostic parameters
- (2007) N. KAPUCUOGLU et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search